Differential induction of nitric oxide, degranulation, and oxidative burst activities in response to microbial agonist stimulations in monocytes and heterophils from young commercial turkeys.
The toll-like receptors (TLRs) recognize microbial pathogens and pathogen-associated molecular patterns and trigger inflammatory immune responses to control the infection. Here, we examined functional innate immune responses to Salmonella enteritidis (SE, live or formalin-killed) and various TLR agonists including lipoteichoic acid (LTA) and peptidoglycan (PGN) from Staphylococcus aureus and synthetic lipoprotein Pam3CSK4 (PAM), poly I:C (synthetic double-stranded RNA analog), lipopolysaccharide (LPS) from S. enteritidis, flagellin (FGN) from S. typhimurium, loxoribine (LOX) and R837 (synthetic anti-viral compounds), and CpG oligodeoxydinucleotide (CpG ODN)by measuring antimicrobial activities including oxidative burst and degranulation in heterophils and nitric oxide production in peripheral blood monocytes. Our results demonstrate differential nitric oxide responses to TLR agonists in turkey monocytes. LTA and CpG ODN were the most potent stimuli for nitric oxide induction followed by PAM, poly I:C, and LPS, whereas FGN, PGN, LOX, R837, and control ODN stimulated little or no nitric oxide production. Live SE stimulated significantly less NO production than formalin-killed SE (FKSE). Although FKSE induced significant degranulation and oxidative burst, most TLR agonists stimulate little oxidative burst and degranulation responses in turkey heterophils.
He
Haiqi
H
Southern Plains Agricultural Research Center, USDA-ARS, SPARC, 2881 F&B Road, College Station, TX 77845, USA. he@ffsru.usda.gov
Genovese
Kenneth J
KJ
Swaggerty
Christina L
CL
Nisbet
David J
DJ
Kogut
Michael H
MH
D000634:Aminoquinolines / Q000494:pharmacology; D000818:Animals; D015550:Cell Degranulation / Q000276:immunology*; D005408:Flagellin / Q000494:pharmacology; D006151:Guanosine / Q000031:analogs & derivatives / Q000494:pharmacology; D000077271:Imiquimod; D007113:Immunity, Innate; D007963:Leukocytes, Mononuclear / Q000276:immunology*; D008070:Lipopolysaccharides / Q000494:pharmacology; D009569:Nitric Oxide / Q000096:biosynthesis* / Q000276:immunology; D010457:Peptidoglycan / Q000494:pharmacology; D011070:Poly I-C / Q000494:pharmacology; D011201:Poultry Diseases / Q000276:immunology* / Q000382:microbiology; D016897:Respiratory Burst / Q000276:immunology*; D012481:Salmonella Infections, Animal / Q000276:immunology / Q000382:microbiology; D012477:Salmonella enteritidis / Q000276:immunology; D013210:Staphylococcus / Q000276:immunology; D013682:Teichoic Acids / Q000494:pharmacology; D051193:Toll-Like Receptors / Q000819:agonists / Q000276:immunology; D014422:Turkeys / Q000097:blood / Q000276:immunology*
D000634:Aminoquinolines; D008070:Lipopolysaccharides; D010457:Peptidoglycan; D013682:Teichoic Acids; D051193:Toll-Like Receptors; D006151:Guanosine; D005408:Flagellin; D009569:Nitric Oxide; C009900:lipoteichoic acid; C068562:loxoribine; D011070:Poly I-C; D000077271:Imiquimod